Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999

Clinical Infectious Diseases

Volumn 32, Issue 10 SUPPL. 2, 2001, Pages

  Diekema, D J ^a   Pfaller, M A ^a   Schmitz, F J ^a   Smayevsky, J ^a   Bell, J ^a   Jones, R N ^a   Beach, M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFEPIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; METICILLIN; OXACILLIN; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CANADA; CENTRAL AMERICA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; EUROPE; NONHUMAN; PACIFIC ISLANDS; PREVALENCE; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; SOUTH AMERICA; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 0035873058     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320184     Document Type: Conference Paper

References (40)

1. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
2. Survey of blood stream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program
3. Trends in antimicrobial susceptibility testing of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America: Report from the SENTRY Antimicrobial Surveillance Program, 1998
4. Bacterial pathogens isolated from patients with skin and soft tissue infections: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
5. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)
6. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
7. Major trends in the microbial etiology of nosocomial infection
8. Methicillin resistant staphylococci
9. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991
10. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
11. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
12. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
13. Emergence of teicoplanin-resistant coagulase-negative staphylococci
14. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides
15. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
16. Surveillance of antimicrobial use and antimicrobiai resistance in United States hospitals: Project ICARE, phase 2
17. Antimicrobial surveillance in key bloodstream bacterial isolates: Electronic surveillance with the Surveillance Network Database - USA
18. Antimicrobial susceptibility of coagulase-negative staphylococci
19. Staphylococcus aureus infections
20. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus
21. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing?
22. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999
23. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk
24. Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain
25. Methicillin-resistant Staphylococcus aureus in Europe
26. Surveillance of antibiotic resistance in Taiwan, 1998
27. Emergence of vancomycin resistance in Staphylococcus aureus
28. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan
29. Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds
30. Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area
31. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada
32. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci
33. Oxazolidinones: A review
34. Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp isolates resistant to quinupristin/dalfopristin
35. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals
36. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998
37. A Dutch approach to methicillin-resistant Staphylococcus aureus
38. Vancomycin-resistant Staphylococcus aureus: Perspectives on measures needed for control